Skip To Main Content
Jason Pugh on Muck Rack

Jason Pugh

United Kingdom
Covers:  Peptides, longevity, senolytics, GLP-1 receptor agonists, nootropics and biohacking. Evidence-led coverage of supplement quality, contamination and what the human trials actually show.
Doesn't Cover: No product launches, testimonials or influencer stories. No general fitness, diet or nutrition. Nothing without published human data.
🧬 Biohacking | Longevity | Peptides Science-backed protocols for human optimisation 🔬 Evidence, not hype. Not medical advice. humanupgradeai.com
Back to Jason Pugh’s profile

Jason Pugh’s Journalist Portfolio

View as a grid

Spermidine and Autophagy: Strong in Mice, Null in Humans

Spermidine and Autophagy: Strong in Mice, Null in Humans

humanupgradeai.com — Spermidine extends lifespan in yeast, flies and mice. The SmartAge human trial found no cognitive benefit. What that gap means in practice.
Who shared?

Peptide Longevity Statistics 2026: Trials, Market & Data

Peptide Longevity Statistics 2026: Trials, Market & Data

humanupgradeai.com — Peptide longevity statistics 2026 reveal 1,872 clinical trials, $48.9 bn market size and 412% GLP-1 growth. Latest registry data, safety updates and real-world usage trends.
Who shared?

FDA Peptide Reclassification 2026: UK & EU Guide

FDA Peptide Reclassification 2026: UK & EU Guide

humanupgradeai.com — The FDA Peptide Reclassification 2026 ends US compounding of 40+ peptides. This guide explains UK & EU legal options, MHRA pathways, testing requirements and safe alternatives for biohackers.
Who shared?

Peptide Contamination Risks & Quality Testing Guide 2026

Peptide Contamination Risks & Quality Testing Guide 2026

humanupgradeai.com — Learn the real peptide contamination risks affecting 15–40% of batches. Discover how UK researchers use independent quality testing, COAs and lab verification to stay safe.
Who shared?

Retatrutide vs Tirzepatide: The Comparative Evidence

Retatrutide vs Tirzepatide: The Comparative Evidence

humanupgradeai.com — Phase 2 trials and network meta-analyses put retatrutide ahead of tirzepatide on mean weight loss. No head-to-head trial has compared them.
Who shared?

GHK-Cu Peptide Reverses Skin Ageing 20-30% in Trials

GHK-Cu Peptide Reverses Skin Ageing 20-30% in Trials

humanupgradeai.com — Discover how GHK-Cu peptide reverses skin ageing 20-30% in human trials, boosts collagen 50-70%, accelerates wounds 2-3x. Dosages, safety, synergies for anti-ageing.
Who shared?

Whole-Body Cryotherapy and Inflammation: The Evidence

Whole-Body Cryotherapy and Inflammation: The Evidence

humanupgradeai.com — Cryotherapy reliably lowers perceived soreness. IL-6 and CRP fall modestly at 24-48 hours, and strength recovery improves less consistently.
Who shared?

Partial Cellular Reprogramming: UK Biohacking Evidence

Partial Cellular Reprogramming: UK Biohacking Evidence

humanupgradeai.com — Learn about partial cellular reprogramming using OSKM factors and its benefits for healthy ageing in this evidence-led UK biohacking article.
Who shared?